Product: Cytarabine Injection, 20 mg/mL, 50 mL Single Dose Vial, Rx only,  antineoplastic/cytotoxic agent; Manufactured for Hospira, Inc., Lake Forest, IL 60045, Product of Australia; NDC 61703-303-46
Reason for recall: The affected lots of Carboplatin Injection, Cytarabine  Injection, Methotrexate Injection, USP, and Paclitaxel Injection are being recalled due to visible particles embedded in the glass located at the neck of the vial. There may be the potential for product to come into contact with the embedded particles and the particles may become dislodged into the solution.
Recall initiated: 20120627
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated